FDA Inspection
Wuxi Fortune Pharmaceutical Co., Ltd.Wuxi Fortune Pharmaceutical Co., Ltd. – FDA Inspection, Jul 28, 2017
Record Details
This FDA Inspection record concerns Wuxi Fortune Pharmaceutical Co., Ltd., with an inspection on July 28, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 573b894a-7ae5-4699-9bff-093582a263f7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1023519
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Wuxi Fortune Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 22, 2024 | Not classified | Office of Inspections and Investigations | |
| September 13, 2023 | Not classified | Office of Inspections and Investigations | |
| September 6, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Wuxi Fortune Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.